Pharmacological blockade of oncogenic MAPK activators drives resistance to cystine deprivation with lipid redox remodeling
{{output}}
Targeted therapies disrupt oncogenic signaling while inducing adaptive metabolic rewiring for cancer cell survival. However, the roles of acute metabolic shifts remain poorly understood. Here, we showed that inhibiting EGFR, KRAS, or BRAF drove resistance to c... ...
